Agency: NIH/NIMH

Agency Award Number: Suppl

An administrative supplement to evaluate the rlationship between biomarkers assessed in various fluids/compartments and the development of, or recovery from, HIV-associated neurocognitive disorders.

Agency: NIH/NIDA

Agency Award Number: R01DA026334

To investigate the effects of COMT genotype on executive functioning, preexisting impulsive traits, measurable behaviors indicating impulsivity and novelty seeking, as well as decision-making choices, on HIV risk behaviors among individuals with METH dependence and/or HIV infection.

Agency: NIH/NIMH

Agency Award Number: R01MH84756

To conduct a multi-parametric examination of neuropathogenetic phenomena that are induced by HIV infection, correlating markers of the disease revealed by different imaging modalities (in vivo and ex vivo) with those localized by specific histological methods to improve our understanding of HIV neuropathogenesis towards the earliest detection by non-invasive means of neurological signs and response to treatment.

Agency: NIH/NIMH

Agency Award Number: K23MH085512

To determine the effect of subclinical malaria on immune activation and the relationships between malaria co-infection, IBs, and NCI in HIV+ individuals in Chennai, India.

Agency: NIH/HNRC
Agency Award Number: HNRC849

This study aims to evaluate the complex interrelationships of white matter abnormalities, ProM, and age as predictors of everyday functioning in HIV disease.

Agency: UCSD
Agency Award Number: RJ059H

To utilize an existing collaboration between SDSU and Universidad Autonoma de Baja California (UABC) to examine the utility of neuropsychological measures in an unstudied, most indigenous population in Mexico.